Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-03

Clinical Trial Update: Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

Clinical trial update for pregabalin in fibromyalgia as part of a post-marketing commitment plan; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Pain Associated With Fibromyalgia | Status: COMPLETED | Results posted: 2019-05-03